Nicotine Gum Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Nicotine Gum Market is Segmented By Type (2 mg, 4 mg), By Application (Withdrawal Clinics, Medical Practice, Individual Smokers), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Online Stores, Others), and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Nicotine Gum Market Size

The Global Nicotine Gum Market reached USD 1.2 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 1.8 billion by 2030. The market is growing at a CAGR of 5.7% during the forecast period 2023-2030. There has been a global surge in the demand for nicotine replacement therapy (NRT) products, including nicotine gum, driven by the increasing number of individuals seeking methods to quit smoking and minimize their exposure to the harmful substances present in tobacco smoke. 

The global nicotine gum market has witnessed several notable trends, such as the development of more convenient and efficient NRT products, including long-lasting gums, and the rising popularity of flavored options. Moreover, there has been a notable rise in the adoption of NRT products for smoking cessation and an increasing number of healthcare professionals endorsing the use of NRT products for their patients.

Additionally, the market key players are concentrating on broadening their range of products and introducing distinctive offerings, including sugar-free gums, to distinguish themselves from competitors and cater to the growing demand for nicotine gum. Manufacturers are also striving to enhance the taste, flavors, and functionality of nicotine gum while employing various marketing campaigns to gain a competitive advantage in the nicotine gum market.

Nicotine Gum Market Scope

To Know More Insights - Download Sample

Nicotine Gum Market Dynamics

Anti-Smoking Campaign Promotion is Encouraged to Boost Market Growth

The market is fueled by a number of factors, including escalating urbanisation, product innovations like the creation of nicotine products (gums), and intensive research and development activities. The use of smoking cessation products, such as nicotine gums and other nicotine replacement products, is encouraged by a number of government and non-governmental organisations (NGOs) in both emerging and developed nations. These organisations focus on helping people, particularly young people, who are addicted to tobacco. Many influential parties support anti-smoking initiatives and frequently introduce products to help people stop smoking, including gum, lozenges, and other items. Combining these products with successful quit programs increases residents' chances of quitting smoking.

Increase in Illness Rate to Support Market Advancement.

Increased attempts to quit smoking as a result of increased public awareness of the health risks associated with smoking is the main factor fueling the market's growth rate. Additionally, the market has seen a marked rise in demand from rehab centers and medical facilities around the world for nicotine cessation treatments in both developed and developing nations. The market is also primarily driven by the rising incidence of certain diseases like lung cancer, cardiac conditions, and respiratory issues. 

For instance, according to the American Cancer Society 2022, there were 1,918,030 new cancer cases and 609,360 cancer deaths are projected to occur in the United States, including approximately 350 deaths per day from lung cancer, the leading cause of cancer death. It actually results from rising tobacco use in distinctive ways that put a significant strain on public safety around the world. These elements could stimulate the market for nicotine gum to grow. 

The Availability of Alternative Smoking Cessation Methods

While nicotine gum is a popular option, there are other forms of NRT available, such as nicotine patches, lozenges, inhalers, and nasal sprays. Some individuals may prefer these alternative methods or find them more convenient, which can impact the demand for nicotine gum. Additionally, the effectiveness of nicotine gum can vary from person to person, and some individuals may not find it as helpful in managing nicotine cravings compared to other options.

Nicotine Gum Market Segment Analysis

The global nicotine gum market is segmented based on type, application, distribution channel and region.

In the Global Market of Nicotine Gum, the 4mg Segment Holds the Largest Market Share. 

Heavy smokers, defined as those who smoke 25 or more cigarettes per day, are often those who chew 4mg of nicotine gum. Since heavy smokers often need a higher quantity of nicotine to feel relief, the 4mg gum's enhanced nicotine content is intended to help smokers better manage their nicotine cravings and withdrawal symptoms. For instance, Glenmark Pharmaceuticals launched 4mg nicotine gum in India. Health benefits of 4mg nicotine gum include aiding smoking cessation by reducing cravings and withdrawal symptoms, leading to improved cardiovascular health, reduced respiratory issues, and lower exposure to harmful chemicals found in cigarettes.

Source: DataM Intelligence Analysis (2023)

Nicotine Gum Market Geographical Share

North America Region Held the Largest Share in Nicotine Gum Market.

With a 32.8% revenue share in 2022, North America dominated the market for nicotine gum. As a result of campaigns and government initiatives that have boosted market expansion in the region, there are more health-conscious consumers in North America. The region is also home to well-known companies like Johnson & Johnson, Cipla Health Limited, Philip Morris, and others that place a high priority on product innovation in order to meet the market's increasing demand and gain a competitive advantage. For instance, on May 17, 2021, North America Generics, Dr. Reddy’s Laboratories, launched 2 mg and 4 mg, the store brand version of Nicorette Lozenges in the U.S. With the introduction of Nicotine Polacrilex Lozenges, the OTC category of smoking cessation products is still committed.

Source: DataM Intelligence Analysis (2023)

Nicotine Gum Market Companies 

The major global players in the market include Cipla Health Limited, Perrigo Company Plc., Teva Canada, Philip Morris, British American Tobacco PLC, Johnson & Johnson, Novartis AG, ITC Limited, Major Pharmaceuticals Inc. and Lil Drug Store Products Inc.

COVID-19 Impact on Nicotine Gum Market

Global Recession/Ukraine-Russia War/COVID-19, and Artificial Intelligence Impact Analysis:

Covid-19 Impact:

The global market has been significantly impacted by COVID-19, with lockdown measures affecting 215 countries. The pandemic has had a moderate impact on the market, with various initiatives being introduced to encourage smoking cessation. For instance, in April 2020, Cipla Health Ltd. launched a '21 Days Challenge to Quit Smoking' campaign, highlighting the health risks of smoking during the pandemic. Health organizations like the WHO and CDC have also advised smokers to quit smoking to combat COVID-19. While nicotine is addictive, non-cigarette forms like nicotine gum can be considered safe. Although the market remained stable during the pandemic, it is expected to recover and regain its market value in the forecast period.

By Type

• 2 mg
• 4 mg

By Application

• Withdrawal Clinics 
• Medical Practice
• Individual Smokers

By Distribution Channel

• Supermarkets/Hypermarkets 
• Convenience Stores
• Online Stores
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • The U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• On February 18, 2022, Betapharm Arzneimittel GmbH and Enorama Pharma's business partnered and launched a generic nicotine chewing gum called Nicotine Beta in Germany. This brand focuses on generic products that emphasize the benefits of nicotine replacement therapy (NRT).
• On April 10, 2022, Johnson & Johnson introduced a digital ecosystem for their Nicorette and NicoDerm products, offering a website that provides assistance to individuals on their smoking cessation journey. The website incorporates a range of resources and tools, such as educational materials, motivation, and support, with the aim of making the process of quitting smoking more manageable.
• On March 12, 2021, Philip Morris International Inc. completed the acquisition of Fertin Pharma, a nicotine gum manufacturer, for a total of USD 813.1 million. By making this strategic move, the company aims to diversify its product portfolio by incorporating a wide array of smoke-free alternatives.

Why Purchase the Report?

• To visualize the global nicotine gum market segmentation based on form, source, application, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities in the market by analyzing trends and co-development. 
• Excel data sheet with numerous data points of nicotine gum market-level with all segments.
• The PDF report consists of cogently put-together market analysis after exhaustive qualitative interviews and in-depth market study.
• Product mapping is available as Excel consists of key products of all the major market players.

The global nicotine gum market report would provide approximately 93 tables, 109 figures and 190 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies